0001181431-13-040876.txt : 20130719 0001181431-13-040876.hdr.sgml : 20130719 20130719185837 ACCESSION NUMBER: 0001181431-13-040876 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130717 FILED AS OF DATE: 20130719 DATE AS OF CHANGE: 20130719 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc CENTRAL INDEX KEY: 0001302573 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 383572512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-995-8200 MAIL ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HASTINGS PAUL J CENTRAL INDEX KEY: 0001309702 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35993 FILM NUMBER: 13977899 MAIL ADDRESS: STREET 1: 61 HARTFORD STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94114 4 1 rrd386069.xml X0306 4 2013-07-17 0 0001302573 OncoMed Pharmaceuticals Inc OMED 0001309702 HASTINGS PAUL J C/O ONCOMED PHARMACEUTICALS, INC. 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 1 1 0 0 President & CEO Stock Option (right to buy) 17.00 2013-07-17 4 A 0 160000 0 A 2023-07-17 Class A Common Stock 160000 160000 D The shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of July 17, 2013, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. The Class A Common Stock will be redesignated "Common Stock" immediately prior to the consummation of the Issuer's initial public offering. /s/ Yvonne Li, Attorney-in-Fact for Paul Hastings 2013-07-19